본문으로 건너뛰기
← 뒤로

The LGALS9/miR-491-5p Axis Regulates CD8 T Cell Function and Inhibits the Progression of Gastric Cancer.

1/5 보강
Cancer science 📖 저널 OA 89.7% 2022: 1/1 OA 2023: 5/5 OA 2024: 13/13 OA 2025: 51/51 OA 2026: 77/94 OA 2022~2026 2026 Vol.117(1) p. 50-62
Retraction 확인
출처

Huang W, Zheng W, Zhu D, Sun Z, Lu W, Tao J, Liu C, Li L, Zhou Y, Fan H, Tao H, Li W

📝 환자 설명용 한 줄

Gastric cancer is a prevalent and clinically significant gastrointestinal malignancy worldwide.

이 논문을 인용하기

↓ .bib ↓ .ris
APA Huang W, Zheng W, et al. (2026). The LGALS9/miR-491-5p Axis Regulates CD8 T Cell Function and Inhibits the Progression of Gastric Cancer.. Cancer science, 117(1), 50-62. https://doi.org/10.1111/cas.70232
MLA Huang W, et al.. "The LGALS9/miR-491-5p Axis Regulates CD8 T Cell Function and Inhibits the Progression of Gastric Cancer.." Cancer science, vol. 117, no. 1, 2026, pp. 50-62.
PMID 41171621 ↗
DOI 10.1111/cas.70232

Abstract

Gastric cancer is a prevalent and clinically significant gastrointestinal malignancy worldwide. Gastric cancer is characterized by limited treatment efficacy and a high recurrence rate. In this study, we found that LGALS9 was highly expressed in gastric cancer and may contribute to disease progression by modulating the infiltration of CD8 T cells. Genetic knockout of LGALS9 reversed T cell function, attenuated immunosuppression, and enhanced the cytotoxic activity of T cells to kill gastric cancer cells. Furthermore, miR-491-5p was identified as a potential suppressor in gastric cancer. The microRNA miR-491-5p regulated T cell-mediated immunity by targeting and inhibiting LGALS9, which was similar to the effect of LGALS9 knockout. Overall, the key target LGALS9 and its inhibitor miR-491-5p represent promising potential for treating gastric cancer.

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

같은 제1저자의 인용 많은 논문 (5)

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반

🟢 PMC 전문 열기